Results per Page:

A quarter century of lifesaving discoveries in prostate cancer
Pacific Northwest Prostate Cancer SPORE insights have transformed patient care and understanding of prostate cancer biology, supported drug discovery worldwide

Tip Sheet: COVID-19 vaccines, SARS-CoV-2 mutations, shedding pandemic pounds – and nematode nerve cells
Summaries of recent Fred Hutch research findings and other news

New awards to spur innovation, commercialization in life sciences research
Funding from Washington Research Foundation continues longstanding collaboration with Fred Hutch

Scientists predict progress against COVID-19, cancer in 2021
After a challenging and deadly 2020, some hopeful predictions for the new year

New protocols, precision approaches ahead for lung cancer
Hutch researchers launch liquid biopsy study; large biomarker protocol publishes, providing ‘roadmap’ for treatment of metastatic patients

New regional collaborations will accelerate innovation in data-intensive medical science
Three research teams in Washington, Oregon and British Columbia receive pilot funding from Cascadia Data Alliance

New Brave Fellowship powers Dr. Alyssa Webster’s race for new leukemia cures
Running community funded new program to develop leaders in rare cancer research and advocates for diversity in science

Shifting liver cancer cells away from migratory state could reduce their drug resistance
Researchers hope lab-based study helps build foundation for personalized treatment of hepatocellular carcinoma

WATCH: Why Dr. Andrew Hsieh is optimistic about the future of treatment for bladder cancer
Physician-scientist aims to make a difference for patients with 'understudied' cancer

Preventing brain metastasis in breast cancer
New $2.4M NCI grant funds research aimed at preventing disseminated tumor cells in the brain from waking up

Identifying the root of prostate cancer treatment resistance using liquid biopsy
Dr. Gavin Ha receives 2019 V Scholar Grant to study whether noninvasive procedure can help monitor and predict how patients will respond to therapy

Consul General of France in San Francisco visits Fred Hutch
Dr. Raphael Gottardo discussed the Hutch’s unique approach to data science

Fred Hutch science and research highlights 2019
Articles showcasing some of the most significant advances in immunotherapy, cell biology and more

What's new in breast cancer research: #SABCS19 edition
Fred Hutch researchers share long-term follow-up data on WHI hormone study, anti-hormone side-effect strategies and more at San Antonio meeting

Fred Hutch receives 5 years of NCI funding to grow and maintain key prostate cancer cohort
$6.7M grant will boost size, participant diversity of Canary Prostate Active Surveillance Study

Fred Hutch–led team receives $6M to study deadly brain tumor
Researchers seek deeper understanding of ependymoma biology to aid treatment discovery

Cancer patients find clinical trials, hope and help
#NWMetsConf connects metastatic breast cancer patients with trials, treatments, tools and each other

Nanotech turns pro-tumor immune cells into cancer-killing triple agents
Strategy doubles survival in mice with cancer

From Omaha to a Seattle lab, with 2 side trips to hell
Childhood AML survivor interns with the scientist who sequenced her genome

Dr. Sita Kugel receives grant to study aggressive form of pancreatic cancer
A new type of NCI award will allow her to pursue novel therapeutic avenues